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Abstract 
Introduction; Neointimal hyperplasia remains an important problem after stent implantation. Previous 
investigations examining vascular responses to stent implantation and effects of drugs have used a retrograde 
deployment approach that may inadvertently alter the local fluid dynamics surrounding the stent. We present a 
model of antegrade iliac artery stent implantation that facilitates the analysis of stent-induced alterations in 
neointimal hyperplasia and wall shear stress in vivo.Methods: Stent delivery catheters were inserted through 
the left carotid artery in anesthetized rabbits (n=37). Catheters were advanced under fluoroscopic guidance to 
the distal iliac arteries, where the stent was deployed. Hemotoxylin and eosin (H&E) staining of unstented and 
stented vascular sections was performed 21 days after implantation. Results: Selective unilateral stent 
implantation was successful in 32 of 37 rabbits. No histological abnormalities were observed in the aorta, 
contralateral unstented iliac, or distal femoral arteries. Neointimal hyperplasia was localized to the stented 
region.Discussion: The model of stent implantation was relatively easy to perform and produced selective 
neointimal hyperplasia within the stented region without evidence of damage, cellular proliferation, or flow 
disruption in the surrounding normal arterial vessels. The model will allow detailed examination of the influence 
of stent implantation on indices of wall shear stress, neointimal hyperplasia, the mechanisms of cellular 
proliferation in vivo, and their modification by drugs. 
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1. Introduction 
Restenosis after stent implantation remains an important clinical problem (Fischman et al., 1994, Holmes et al., 
1998, Serruys et al., 1994, van Beusekom et al., 1998). Stent implantation acutely restores blood flow distal to 
vascular stenoses but may be associated with cellular damage (Rogers et al., 1999, Schwartz et al., 1992). Recent 
data indicate that spatial distributions of shear stress mediate the rate and location of smooth muscle cell 
migration and proliferation after vascular injury (Liu & Goldman, 2001, Liu et al., 2002), suggesting that stent 
geometry and deployment ratio may differentially influence restenosis after implantation. We have previously 
demonstrated that design properties unique to the geometry of an implanted stent differentially influence the 
area of idealized computational vessels subjected to indices of wall shear stress associated with vascular 
susceptibility to neointimal hyperplasia using 3D computational fluid dynamics models (LaDisa et al., 
2003, LaDisa et al., 2004). The current report presents a methodology that has been developed to test these 
computational findings experimentally using an antegrade stent implantation model in rabbits. 
Previous models of stent implantation in rabbit iliac arteries have used retrograde stent placement performed 
through the femoral artery (Burgio et al., 1984, Garasic et al., 2000, Herdeg et al., 2003). However, this 
retrograde model may introduce alterations in the localized flow environment distal to the stent, which may 
subsequently influence cellular proliferation within the stented region, and is not representative of typical 
catheter entrance to regional vascular lesions. We present an antegrade model of stent implantation that can be 
used to investigate spatial and temporal alterations in neointimal hyperplasia within the interventional region in 
the absence of flow disturbances introduced by the method of deployment. We have preliminarily reported the 
use of this model to compare temporal alterations in vascular histology with concomitant alterations in indices 
of wall shear stress after stent implantation (LaDisa, Warltier et al., 2004). These data suggest a high correlation 
between areas of low wall shear stress and neointimal hyperplasia within the stented zone. We also 
demonstrate how the model can also be employed to analyze the local expression of molecular mediators that 
contribute to cellular proliferation within the stented region to elucidate mechanisms of restenosis. 
2. Methods 
2.1. Use and care of animals 
All experimental procedures and protocols used in this investigation were approved by the Animal Care and Use 
Committee of Marquette University and the Medical College of Wisconsin. Furthermore, all conformed to 
the Guiding Principles in the Care and Use of Animals of the American Physiological Society and the Guide for the 
Care and Use of Laboratory Animals as outlined by the National Institutes of Health (7th ed. Washington, DC: 
Nat. Acad. Press, 1996). 
2.2. Antegrade iliac artery stent implantation 
Male New Zealand white rabbits (n=37) weighing approximately 3.5 kg were obtained from New Franken 
Researchers (New Franken, WI). The rabbit iliac artery was selected for stent implantation because the diameter 
and length of this vessel closely approximates the size of stents frequently used in clinical settings (3.0 and 16 
mm, respectively). The absence of axial curvature in these arteries and the ability to obtain experimental (stent) 
and chronic control data in the contralateral iliac arteries of a single animal are also important benefits of this 
model. Stent implantation was performed under sterile conditions using portable fluoroscopic imaging (OEC, GE 
Medical Systems, Milwaukee, WI). Rabbits were anesthetized intravenously through the right marginal ear vein 
with a mixture of xylazine (2.2 mg/kg) and ketamine (22 mg/kg) and intubated using a 3.0-mm pediatric 
endotracheal tube. Anesthesia was maintained with 1% to 2% isoflurane in oxygen, and rabbits were allowed to 
breathe spontaneously. Body temperature was controlled at 37 °C through the use of a heating pad. 
An incision was made above the left carotid artery and the vessel dissected free. A 5F introducer sheath 
(Avanti+, Cordis, Miami, FL) was inserted into the vessel, through which a fluid-filled 5F JR3.5-5 softip guide 
catheter, preloaded with a guide wire (Entre II; Boston Scientific, Maple Grove, MN), was advanced from the 
carotid artery into the distal descending aorta. The guide wire was then advanced to the proximal portion of the 
right iliac artery. The contralateral iliac artery was not instrumented and served as a control. The guide catheter 
was carefully removed while the wire remained in place. The stent delivery system was advanced to the distal 
portion of the iliac artery using the guide wire and the stent was deployed to a pressure of 5 atm to achieve a 
stent-to-artery-size ratio range of 1.1 to 1.2:1 (Garasic et al., 2000). Intravenous heparin (100 U/kg) was 
administered immediately after stent deployment (Rogers & Edelman, 1995). Successful deployment was 
verified by angiography, and the stent delivery catheter was removed. The left carotid artery was ligated, the 
incision above the carotid artery closed in layers, and the rabbit allowed to emerge from anesthesia. 
Intramuscular buprenorphine (0.05 mg/kg, BID) was used for the treatment of postoperative pain. Rabbits also 
received antibiotic prophylaxis (enrofloxacin, 5 mg/kg) for 4 days after stent implantation and aspirin in their 
drinking water (20 mg/day) for the duration of the protocol (Rogers & Edelman, 1995). 
2.3. Histological analysis 
Additional rabbits (n=12) were used for histological analysis of stented and unstented arteries. Rabbits 
underwent iliac artery stent implantation as described above and were sacrificed 21 days after deployment. On 
the day of sacrifice, rabbits were anesthetized as previously described, the chest opened by a midline 
sternotomy, and the pericardium incised. The apex of the left ventricle was perfused at a mean arterial pressure 
of 100 mm Hg with lactated Ringer's solution, followed by Carnoy's solution (Rogers, Edelman, & Simon, 1998) 
while the rabbit was simultaneously exsanguinated through a right atrial incision. The proximal and distal ends 
of the iliac arteries were identified, and the vessels were carefully excised and fixed in Carnoy's solution for 4 h. 
Samples were then subjected to iterative dehydration and embedded in glycol methyl methacrylate (Technovit 
7100, EB Sciences, Agawam, MA). 
Specimens were sectioned at room temperature in 5-μm intervals using a microtome equipped with a tungsten 
carbide knife that facilitated direct sectioning through the stainless steel linkages of the implanted stent 
(Delaware Diamond Knives, Ted Pella, Redding, CA). Histological sections were floated on a warm water bath, 
mounted on positively charged Colorfrost Plus microscope slides (Fisher Scientific, Pittsburgh, PA), dried, and 
refrigerated at 4 °C until histological analysis. Hemotoxylin and eosin (H&E) staining was used to identify the 
nuclei, cytoplasmic structures, and extracellular components in stented and unstented arterial sections. Light 
photomicrographs were obtained using a Nikon Optiphot-2 microscope (Tokyo, Japan) equipped with a 
Diagnostics SPOT CCD camera (Sterling Heights, MI). 
2.4. Immunohistochemistry 
Sections were treated with 0.1% trypsin in phosphate-buffered saline (PBS) at room temperature for 1 h prior to 
staining to increase the permeability of the plastic sections (Burgio et al., 1984). Sections were then incubated 
with a 1:200 dilution of a mouse monoclonal primary antibody for α-smooth muscle actin (Sigma, St. Louis, MO) 
in PBS at 37 °C for 30 min. Sections were washed three times for 5 min with PBS and subsequently incubated 
with a 1:200 dilution of biotinylated antimouse secondary antibody (Amersham Pharmacia Biotech, UK) in PBS at 
37 °C for 30 min. Sections were washed three times for 5 min with PBS before conjugation with 10 μg/ml 
streptavidin-labeled Texas Red (sulfonyl chloride; Pierce, Rockford, IL) at 37 °C for 15 min. Sections were again 
washed three times for 5 min with PBS, and nuclear staining was achieved by including 1 μm of TO-PRO-3 
(Molecular Probes, Eugene, OR) during the final rinse. Images were obtained using a laser fluorescence imaging 
system and a confocal microscope. A krypton–argon laser was used for excitation wavelengths of 545 and 642 
nm, and emitted fluorescence was determined after long-pass filtering at corresponding wavelengths of 578 and 
661 nm for Texas Red and TO-PRO, respectively. 
3. Results 
Thirty-seven rabbits were anesthetized, and 32 stents were successfully implanted. The average experimental 
time was 77±25 min (mean±S.D.) from induction until emergence from general anesthesia. The introduction of 
stent delivery catheters through the left carotid artery facilitated access to the distal iliac arteries where stent 
deployment was performed. The transition from the common carotid artery to the aortic arch presented an 
anatomical obstacle to stent implantation in four initial experiments. This difficulty was overcome in subsequent 
placement attempts by using contrast media injected into the aortic arch through JR3.5-5 softip guide catheters. 
The guide catheter was orientated dorsally under fluoroscopic guidance, and the preloaded guide wire was 
directed away from the aortic valve into the ascending aorta. The guide catheter was subsequently advanced, 
the guide wire retracted into the catheter, and the two carefully advanced into the distal aorta. The iliac artery 
illumination using contrast media, positioning of the stent delivery catheter, deployment and mechanical 
deformation of the associated stent, and removal of the delivery catheter are illustrated in Fig. 1. One additional 
rabbit was sacrificed because embolization of a thrombus into the distal iliac artery occurred immediately after 
stent implantation. 
 
Fig. 1. Angiographic images of antegrade stent implantation. A 5F guide catheter and guide wire were 
introduced through the carotid artery and advanced into the distal descending aorta. A contrast media was 
administered to identify the iliac arteries (A). The guide wire was then advanced to the right iliac artery. A stent 
delivery system was advanced to the artery using the guide wire (B), and the stent was carefully deployed to 5 
atm to achieve a stent-to-artery ratio range of 1.1 to 1.2:1 (C). The stent delivery catheter was then removed, 
leaving the implanted stent, as depicted within the ellipsoid of Panel D. 
 
Antegrade stent implantation into the right iliac artery was not associated with histological evidence of aortic 
injury (Fig. 2A). Stent implantation also did not alter the histology of the contralateral iliac or distal femoral 
arteries, as indicated by the intact endothelial, internal elastic lamina, and medial layers (Fig. 2B to D). 
Histological analysis of stented iliac arteries revealed neointimal hyperplasia localized to the stented portion of 
the artery (Fig. 3). Immunohistochemical analysis of unstented vessels confirmed that that cells within the 
medial layer were of α-actin smooth muscle origin (Fig. 4, left). Autofluorescence of the internal elastic lamina 
was detected and separated the boundary of the medial layer from the nuclei of endothelial cells lining the 
luminal surface. These cells and those within the medial and advential layers were successfully stained by TO-
PRO-3. The fluorescent photomicrograph presented in the right panel of Fig. 4 reveals stretching of the internal 
elastic lamina caused by stent placement, consistent with Fig. 3. The figure also demonstrates that much of the 
neointimal hyperplasia contains cells positive for α-actin. Fig. 4 further illustrates that there are regions adjacent 
to the stent strut and lining the luminal surface that are devoid of smooth muscle α-actin, but do contain intact 
nuclei. 
 
Fig. 2. Histological sections stained with H&E illustrating normal intimal, medial, and adventitial layers of a 
descending aorta (A, ×10), contralateral unstented iliac artery (B, ×20), and left and right femoral arteries (C and 
D, respectively, ×20) after antegrade stent implantation. Iliac artery cross-sections are arranged with the 
vascular lumen orientated toward the upper left corner of each image. 
 
 
Fig. 3. Histological cross-section stained with H&E within the stented portion of an interventional iliac artery 
(×10). The iliac artery cross-section is arranged with the vascular lumen (L) orientated toward the left side of the 
image, and stent struts (S) have been labeled for clarity. 
 
 
Fig. 4. Fluorescence photomicrographs (×10) of contralateral unstented and stented iliac arteries stained with 
antibodies against α-actin smooth muscle and cell nuclei. The iliac artery cross-sections are arranged with the 
vascular lumen (L) orientated toward the left side of the image. The internal elastic lamina has been traced, and 
stent struts have been outlined and labeled for clarity. 
 
4. Discussion 
We report a model of antegrade stent implantation that does not produce vascular injury and preserves the flow 
domain near the site of an implanted stent. Previous studies were conducted in rabbit iliac arteries using a 
retrograde stent implantation technique through the femoral artery (Garasic et al., 2000, Herdeg et al., 2003). 
These previous studies have provided information about the stent-induced development of neointimal 
hyperplasia, but neglected potentially influential alterations in the blood flow environment within the stented 
region after deployment. The current histological results of the stented region demonstrated appreciable 
neointimal growth within this vascular segment. Our preliminary data shown in Fig. 5 indicate that these 
histological findings correlate closely with temporal alterations in spatial distributions of wall shear stress, as 
determined from the computational fluid dynamics analysis of unstented and stented iliac artery flow domains 
obtained using microfocal X-ray computed tomography imaging (LaDisa, Warltier et al., 2004). The figure depicts 
normalized distributions of wall shear stress in an unstented iliac artery and stented iliac arteries immediately 
after stent deployment, or 21 days after implantation, using the methods presented in this report. 
 
Fig. 5. Normalized distributions of wall shear stress in an unstented iliac artery (top) and stented iliac arteries 
immediately after deployment (theoretical, middle) or 21 days after antegrade stent implantation in vivo 
(bottom). Histological cross-section stained with H&E (×10) in the proximal, middle, and distal regions of the 
stent 21 days after implantation are depicted according to their respective spatial locations. 
 
Previous studies have demonstrated that regions of low wall shear stress and elevated spatial wall shear stress 
gradients may be spatially colocalized to sites of neointimal hyperplasia (Kleinstreuer et al., 2001). Distributions 
of wall shear stress are lower within the stented region of the vessel, and this reduction in wall shear stress is 
most pronounced at the inlet of the stented region (Fig. 5). We have also recently reported that elevated spatial 
wall shear stress gradients are greatest in transition regions between the stent and native vessel as a result of 
the increased luminal diameter necessary to firmly anchor the stent into the vessel wall (LaDisa, Olson et al., 
2004). Interestingly, analyses of histological cross-sections corresponding to the proximal, middle, and distal 
regions of the stent, 21 days after implantation, reveal appreciable neointimal hyperplasia at the entrance and 
exit of the stent and modest cellular proliferation within the middle of the stent. 
The present model may be used with immunohistochemistry to investigate the molecular mechanisms 
associated with neointimal hyperplasia that develops in response to stent deployment and subsequent 
alterations in indices of wall shear stress within the stented region. In the current report, immunohistochemical 
analysis was used to reveal the localized expression of α-smooth muscle actin and cellular nuclei in stented and 
unstented iliac arteries (Fig. 4). We plan to use the present methods to colocalize additional molecular targets 
using double-staining techniques. Thus, the current model may facilitate future investigation of altered fluid 
dynamics, indices of wall shear stress, and the molecular mechanisms mediating neointimal hyperplasia after 
stent implantation in vivo. 
The current method of antegrade stent implantation may be associated with several potential limitations that 
warrant additional comment. Stents were relatively easily implanted in healthy rabbit iliac arteries, but technical 
difficulties may be encountered when stent deployment is attempted in the presence of atherosclerosis. The 
mechanisms responsible for neointimal hyperplasia in normal as compared with atherosclerotic vessels may also 
be different. Previous studies have demonstrated that the greatest inflammatory reaction to stent implantation 
is localized to regions where the stent is in direct apposition to the intima (Farb et al., 1999, Farb et al., 2002). 
Thus, the present histological results obtained in circumferentially homogenous normal rabbit iliac arteries may 
be different from those observed in vessels containing eccentrically localized atherosclerotic plaques. The 
composition of neointimal hyperplasia that develops in animals differs from that observed in humans (Bennett & 
O'Sullivan, 2001). Furthermore, the onset and development of neointimal hyperplasia after stent implantation is 
more rapid in animals than in humans (Orford, Selwyn, Ganz, Popma, & Rogers, 2000). Nevertheless, neointimal 
hyperplasia occurs consistently throughout mammalian species in response to direct stimulation of endothelial 
cells. 
Atherosclerosis is most often precipitated by elevated concentrations of circulating low-density lipoprotein 
cholesterol that promote leukocyte adhesion, rolling, and extravasation (Krieglstein & Granger, 2001). The 
placement of a stent may contribute to further chronic vascular injury and restenosis despite the initial 
restoration of blood flow distal to the atherosclerotic plaque. In the current model of neointimal hyperplasia, 
the initial vascular damage was instead caused by the deployment of the stent. Despite these differing 
mechanisms of vascular injury, the neointimal hyperplasia that occurs in animal models of stent implantation 
appears to closely resemble that observed in humans, albeit in an accelerated time frame (Virmani, Kolodgie, 
Farb, & Lafont, 2003). Moreover, many of the current criteria required for a stent delivery device to gain Food 
and Drug Administration approval are based on findings from animal models of vascular injury. Thus, the current 
model of rabbit antegrade iliac artery stent deployment may be particularly useful for the comprehensive 
examination of vascular responses to stent deployment, as it provides a highly reproducible method of 
producing and assessing cellular proliferation after implantation (Bennett & O'Sullivan, 2001, Narayanaswamy et 
al., 2000, Orford et al., 2000). 
In summary, we report the details of a model of antegrade iliac artery stent placement developed to allow the 
investigation of the influence of stent-induced alterations in indices of wall shear stress on neointimal 
hyperplasia in vivo. In a preliminary investigation, neointimal hyperplasia was greatest in regions exposed to low 
wall shear stress and elevated spatial wall shear stress gradients (LaDisa, Warltier et al., 2004). Moreover, there 
was a temporally dependent inverse relationship between wall shear stress and the severity of neointimal 
hyperplasia. This suggests that stent implantation may introduce spatial alterations in wall shear stress that 
modulate the growth of neointimal hyperplasia to temporally abolish wall shear stress disparity in vivo. The 
present experimental methodology is highly reproducible and produces selective neointimal hyperplasia within 
the stented region of the vessel after implantation in the absence of cellular proliferation proximal and distal to 
the site of deployment. This model will facilitate additional study of the mechanisms associated with neointimal 
hyperplasia after stenting in the absence of complicating localized disruptions of fluid dynamics caused by 
retrograde implantation that may inadvertently also affect cellular proliferation. 
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